ClinicalKey AI Wins “AI Innovation Award” in 8th Annual MedTech Breakthrough Awards Program

Elsevier, a global leader in scientific information and data analytics, has been selected as winner of the “AI Innovation Award” in the 8^th annual MedTech Breakthrough Awards program. MedTech Breakthrough 新しいタブ／ウィンドウで開く, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, presented Elsevier with the award for the breakthrough innovation of Elsevier’s ClinicalKey AI.

Elsevier partnered with OpenEvidence to develop ClinicalKey AI, expanding ClinicalKey’s capabilities with the latest AI advancements. ClinicalKey AI combines trusted, evidence-based clinical content with conversational search powered by generative AI to support clinicians in delivering high-quality patient care.

ClinicalKey AI generates responses based on information from validated sources, including Elsevier’s proprietary point of care content, medical reference texts, Elsevier and trusted third-party journal abstracts, and government publications. By evaluating these evidence-based content sources that are updated daily, ClinicalKey AI can summarize a tailored response to clinical queries. Responses also include references with linked citations to supporting published evidence.

“As a company dedicated to empowering clinicians and improving outcomes, we are committed to ensuring clinicians have access to reliable, evidence-based medical information. ClinicalKey AI is designed for clinical practice, and enables faster and more precise answers to a wide variety of clinical questions based on the latest scientific research,” said Jan Herzhoff, President of Health Markets at Elsevier. “This is critical given the overwhelming volume of complex cases that clinicians are required to manage every day. ClinicalKey AI sets a new standard for medical decision-making support, and we are delighted to be recognized by MedTech Breakthrough with the AI Innovation Award.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and many more. This year’s program attracted thousands of nominations from over 18 different countries throughout the world.

“ClinicalKey AI makes it possible for clinicians to easily extract precise knowledge from the vast body of clinical information, ensure decisions are based on the latest evidence, and help hospital leaders provide the right AI technology for supporting clinical decision making,” said Steve Johansson, managing director, MedTech Breakthrough. “We’re proud to award Elsevier’s solution with AI Innovation for this year’s MedTech Breakthrough Award.”

By building upon AI technology designed for healthcare and tested by over 30,000 clinicians, Elsevier continues their commitment to responsible AI. They continuously evaluate the accuracy of ClinicalKey AI’s output with their team of over 100 clinicians and their two health system development partners. Debuting with live demonstrations at HIMSS this year, ClinicalKey AI shows the power of AI innovation in healthcare, backed by AI safeguards and trusted evidence-based content.

ClinicalKey AI allows clinicians to ask questions the way they would speak to a trusted specialist and receive answers quickly. The solution’s intuitive clinical reasoning assistant is designed so clinicians can quickly search a comprehensive base of clinical knowledge. Clinicians can access this information at the point of care, while also accounting for patient context—including multiple comorbidities and current medications. All of this can be personalized to the individual user within their profile settings.

ClinicalKey AI allows clinicians to explore a variety of disease conditions and treatment options. Hospital leaders are then able to build a sustainable culture around evidence-based practice, which can help manage costs and enhance patient care.

####

About MedTech Breakthrough

Part of Tech Breakthrough 新しいタブ／ウィンドウで開く, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com 新しいタブ／ウィンドウで開く.

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

エルゼビアについて エルゼビアは、科学情報と分析を牽引するグローバル企業として、研究者や医療従事者が社会の利益のために科学を進歩させ、医療成果を向上させることを支援しています。我々は信頼できるエビデンスベースのコンテンツと高度なAI対応デジタルテクノロジーに基づくソリューションにより、インサイトと重要な意思決定を促進することでこれを実現しています。

エルゼビアは、140 年以上にわたり研究および医療コミュニティの活動を支援してきました。全世界で 2,500 人以上の技術者を含む 9,500 人の従業員がおり、重要な職務における研究者や、図書館員、アカデミックリーダー、資金提供者、政府機関、R&D 関連企業、医師、看護師、将来の医療従事者や教育者を支援することに従事してきました。2,900 誌以上の科学ジャーナルと代表的な参考文献には、Cell Press、The Lancet、Gray's Anatomy など、各分野の主要なタイトルを含みます。 エルゼビア・ファウンデーション 新しいタブ／ウィンドウで開くと共に、開発途上国および世界中の科学、研究、医療分野におけるインクルージョン＆ダイバーシティを推進するため、支援コミュニティと連携して活動しています。 エルゼビアは、プロフェッショナルおよびビジネス顧客向けの情報に基づく分析および意思決定ツールのグローバルプロバイダーである RELX 新しいタブ／ウィンドウで開くグループの一部です。業務内容やデジタルソリューション、コンテンツ詳細については、 www.elsevier.com/ja-jpをご参照ください。